Marylyn Addo
Prof. Dr. med.
Marylyn Addo
  • Oberärztin und Leiterin Sektion Infektiologie
  • ***Presseanfragen richten Sie bitte an ""
  • ***Studienanfragen richten Sie bitte an ""
  • Fachärztin für Innere Medizin



Hauptgebäude O10 , 2. Etage
Deutsch (Muttersprache)







  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2005
  • 2001
  • 2000
  • 1999
  • 1998
  • 1995

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
Badbaran A, Mailer R, Dahlke C, Woens J, Fathi A, Mellinghoff S, Renné T, Addo M, Riecken K, Fehse B
MOL THER-METH CLIN D. 2021;23:418-423.

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
Brehm T, Pfefferle S, von Possel R, Kobbe R, Nörz D, Schmiedel S, Grundhoff A, Olearo F, Emmerich P, Robitaille A, Günther T, Braun P, Andersen G, Knobloch J, Addo M, Lohse A, Aepfelbacher M, Fischer N, Schulze Zur Wiesch J, Lütgehetmann M
VIRUSES-BASEL. 2021;13(4):.

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center:A sequential follow-up study
Brehm T, Schwinge D, Lampalzer S, Schlicker V, Küchen J, Thompson M, Ullrich F, Huber S, Schmiedel S, Addo M, Lütgehetmann M, Knobloch J, Schulze Zur Wiesch J, Lohse A
INT J HYG ENVIR HEAL. 2021;232:113671.

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza
Brehm T, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo M, Schmiedel S, Kluge S, Schulze Zur Wiesch J
SCI REP-UK. 2021;11(1):5803.

Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis
Buescher G, Ozga A, Lorenz E, Pischke S, May J, Addo M, Horvatits T
LIVER INT. 2021;41(3):449-455.

Integrin alpha E (CD103) limits virus-induced IFN-I production in conventional dendritic cells
Duhan V, Khairnar V, Kitanovski S, Hamdan T, Klein A, Lang J, Ali M, Adomati T, Bhat H, Friedrich S, Li F, Krebs P, Futerman A, Addo M, Hardt C, Hoffmann D, Lang P, Lang K
FRONT IMMUNOL. 2021 [Epub ahead of print].

Clinical presentation and disease course of 37 consecutive cases of progressive multifocal leukoencephalopathy (PML) at a German tertiary-care hospital: a retrospective observational study
Graf L, Rosenkranz S, Hölzemer A, Hagel C, Goebell E, Jordan S, Friese M, Addo M, Schulze zur Wiesch J, Beisel C
FRONT NEUROL. 2021;12:632535.

Longitudinal development of antibody responses in covid-19 patients of different severity with elisa, peptide, and glycan arrays: An immunological case series
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco B, Ly M, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt N, Seeberger P, Addo M, Loeffler F
PATHOGENS. 2021;10(4):.

Hepatitis E virus persists in the ejaculate of chronically infected men
Horvatits T, Wißmann J, Johne R, Groschup M, Gadicherla A, Wiesch J, Eiden M, Todt D, Reimer R, Dähnert L, Schöbel A, Horvatits K, Lübke R, Wolschke C, Ayuk F, Rybczynski M, Lohse A, Addo M, Herker E, Lütgehetmann M, Steinmann E, Pischke S
J HEPATOL. 2021;75(1):55-63.

Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness
Jochum J, Kreuels B, Tannich E, Huber S, Schulze Zur Wiesch J, Schmiedel S, Ramharter M, Addo M
TROP MED INFECT DIS. 2021;6(2):.

SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
Ruether D, Schaub G, Duengelhoef P, Haag F, Brehm T, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, Fischer L, Addo M, Lütgehetmann M, Lohse A, Schulze Zur Wiesch J, Sterneck M
CLIN GASTROENTEROL H. 2021 [Epub ahead of print].

Less than you’d think - a prospective study on MRSA-colonization in healthy travelers
Tran D, Winter D, Christner M, Ramharter M, Addo M, Rolling T, Vinnemeier C, Koch T
J TRAVEL MED. 2021;28(3):.

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik : Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
von Felden J, Brehm T, Schulze Zur Wiesch J, Addo M, Lohse A, Knobloch J, Koch T
BUNDESGESUNDHEITSBLATT. 2021 [Epub ahead of print].

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
von Felden J, Brehm T, Schulze-Zur-Wiesch J, Addo M, Lohse A, Knobloch J, Koch T
BUNDESGESUNDHEITSBLATT. 2021;64(9):1165-1168.

B cell analysis in SARS‐CoV‐2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID‐19
Wildner N, Ahmadi P, Schulte S, Brauneck F, Kohsar M, Lütgehetmann M, Beisel C, Addo M, Haag F, Schulze zur Wiesch J
J LEUKOCYTE BIOL. 2021;109(1):77-90.

Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
Woo M, Haag F, Nierhaus A, Jarczak D, Roedl K, Mayer C, Brehm T, van der Meirschen M, Hennigs A, Christopeit M, Fiedler W, Karagiannis P, Burdelski C, Schultze A, Huber S, Addo M, Schmiedel S, Friese M, Kluge S, Schulze Zur Wiesch J
ISCIENCE. 2021;24(7):102752.

Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients
Zhao Y, Kilian C, Turner J, Bosurgi L, Roedl K, Bartsch P, Gnirck A, Cortesi F, Schultheiß C, Hellmig M, Enk L, Hausmann F, Borchers A, Wong M, Paust H, Siracusa F, Scheibel N, Herrmann M, Rosati E, Bacher P, Kylies D, Jarczak D, Lütgehetmann M, Pfefferle S, Steurer S, Zur Wiesch J, Puelles V, Sperhake J, Addo M, Lohse A, Binder M, Huber S, Huber T, Kluge S, Bonn S, Panzer U, Gagliani N, Krebs C
SCI IMMUNOL. 2021;6(56):.

Antibiotikatherapie richtig gemacht
Addo M, Thimme R
DEUT MED WOCHENSCHR. 2020;145(23):1657.

Seroconversion of HBsAG coincides with hepatitis A super-infection: A case report
Beisel C, Addo M, Zur Wiesch J
WORLD J CLIN CASES. 2020;8(9):1651-1655.

Risk factors for different intestinal pathogens among patients with traveler's diarrhea: A retrospective analysis at a German travel clinic (2009-2017)
Brehm T, Lütgehetmann M, Tannich E, Addo M, Lohse A, Rolling T, Vinnemeier C
TRAVEL MED INFECT DI. 2020;37:101706.

High effectiveness of multimodal infection control interventions in preventing SARS−CoV−2 infections in healthcare professionals: a prospective longitudinal seroconversion study
Brehm T, Schwinge D, Lampalzer S, Schlicker V, Küchen J, Thompson M, Ullrich F, Huber S, Schmiedel S, Addo M, Lütgehetmann M, Knobloch J, Schulze zur Wiesch J, Lohse A
medRxiv BMJ. 2020.

Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
Dahlke C, Fathi A, Addo M
FRONT IMMUNOL. 2020;11(11):601170.

Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
Dahlke C, Heidepriem J, Kobbe R, Santer R, Koch T, Fathi A, Ly M, Schmiedel S, Seeberger P, , Addo M, Loeffler F
medRxiv. 2020.

Usp18 Expression in CD169+ Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV
Friedrich S, Schmitz R, Bergerhausen M, Lang J, Cham L, Duhan V, Häussinger D, Hardt C, Addo M, Prinz M, Asano K, Lang P, Lang K
VACCINES-BASEL. 2020;8(1):.

Validation of a prospective urinalysis-based prediction model for ICU-resources and outcome of Covid-19 disease: A multicenter cohort study
Gross O, Moerer O, Rauen T, Böckhaus J, Hoxha E, Jörres A, Windisch W, Dreher M, Floege J, Kluge S, Schmidt-Lauber C, Turner J, Huber S, Addo M, Scheithauer S, Friede T, Braun G, Huber T, Blaschke S
Research Square Preprint. 2020.

Epitopes of Naturally Acquired and Vaccine-Induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution
Heidepriem J, Krähling V, Dahlke C, Wolf T, Klein F, Addo M, Becker S, Loeffler F
BIOTECHNOL J. 2020;15(9):e2000069.

Relapsing cutaneous leishmaniasis in a patient requiring TNF-α-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature
Heinemann M, Omansen T, Hennigs A, Völker K, Menz A, Addo M, Schmiedel S
TRAVEL MED INFECT DI. 2020;37:101700.

Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection
Horvatits T, Schulze Zur Wiesch J, Polywka S, Buescher G, Lütgehetmann M, Hussey E, Horvatits K, Peine S, Haag F, Addo M, Lohse A, Weiler-Normann C, Pischke S
PATHOGENS. 2020;9(9):.

No link between male infertility and HEV genotype 3 infection
Horvatits T, Varwig-Janssen D, Schulze Zur Wiesch J, Lübke R, Reucher S, Frerk S, Addo M, Schneider S, Lohse A, Luetgehetmann M, Pischke S
GUT. 2020;69(6):1150-1151.

Scent dog identification of samples from COVID-19 patients - a pilot study
Jendrny P, Schulz C, Twele F, Meller S, von Köckritz-Blickwede M, Osterhaus A, Ebbers J, Pilchová V, Pink I, Welte T, Manns M, Fathi A, Ernst C, Addo M, Schalke E, Volk H
BMC INFECT DIS. 2020;20(1):536.

Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
Karakas M, Jarczak D, Becker M, Roedl K, Addo M, Hein F, Bergmann A, Zimmermann J, Simon T, Marx G, Lütgehetmann M, Nierhaus A, Kluge S
BIOMOLECULES. 2020;10(8):.

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba N, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly M, Zinser M, Bartels E, Poetsch J, Neumann R, Fux R, Schmiedel S, Lohse A, Haagmans B, Sutter G, Becker S, Addo M
LANCET INFECT DIS. 2020;20(7):827-838.

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
Koch T, Rottstegge M, Ruibal P, Gomez-Medina S, Nelson E, Escudero-Pérez B, Pillny M, Ly M, Koundouno F, Bore J, Magassouba N, Dahlke C, Günther S, Carroll M, Addo M, Muñoz-Fontela C
VIRUSES-BASEL. 2020;12(9):.

Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19
Malsy J, Veletzky L, Heide J, Hennigs A, Gil-Ibanez I, Stein A, Lütgehetmann M, Rosien U, Jasper D, Peine S, Hiller J, Haag F, Schmiedel S, Huber S, Jordan S, Addo M, Schulze Zur Wiesch J

Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination
Pejoski D, de Rham C, Martinez-Murillo P, Santoro F, Auderset F, Medaglini D, Pozzi G, Vono M, Lambert P, Huttner A, Haks M, Ottenhoff T, Villard J, Siegrist C
NPJ vaccines. 2020;5(1):32.

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
Pflüger L, Bannasch J, Brehm T, Pfefferle S, Hoffmann A, Nörz D, van der Meirschen M, Kluge S, Haddad M, Pischke S, Hiller J, Addo M, Lohse A, Wiesch J, Peine S, Aepfelbacher M, Lütgehetmann M
J CLIN VIROL. 2020;130:104549.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez J, Perez Marc G, Moreira E, Zerbini C, Bailey R, Swanson K, Roychoudhury S, Koury K, Li P, Kalina W, Cooper D, Frenck Jr R, Hammitt L, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan D, Mather S, Dormitzer P, Sahin U, Jansen K, Gruber W
NEW ENGL J MED. 2020;383(27):2603-2615.

Von den Toten lernen - neue Erkenntnisse zu Covid-19
Püschel K, Kluge S, Addo M, Aepfelbacher M
Hamb Ärztebl. 2020;73(06):34-36.

Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease
Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, Sedding D, Ciesek S, Addo M, Binder M
IMMUNITY. 2020;53(2):442-455.e4.

Integration of microarray data and literature mining identifies a sex bias in DPP4+CD4+ T cells in HIV-1 infection
Stubbe H, Dahlke C, Rotheneder K, Stirner R, Roider J, Conca R, Seybold U, Bogner J, Addo M, Draenert R
PLOS ONE. 2020;15(9):e0239399.

COVID19: Where are we now?
von Bergwelt Baildon M, Addo M
DEUT MED WOCHENSCHR. 2020;145(15):1019.

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann D, Sperhake J, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder A, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen H, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo M, Aepfelbacher M, Püschel K, Kluge S
ANN INTERN MED. 2020;173(4):268-277.

Frequent neurocognitive deficits after recovery from mild COVID-19
Woo M, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo M, Gerloff C, Heesen C, Schulze zur Wiesch J, Friese M
BRAIN COMMUN. 2020;2(2):fcaa205.

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Ehrhardt S, Zehner M, Krähling V, Cohen-Dvashi H, Kreer C, Elad N, Gruell H, Ercanoglu M, Schommers P, Gieselmann L, Eggeling R, Dahlke C, Wolf T, Pfeifer N, Addo M, Diskin R, Becker S, Klein F
NAT MED. 2019;25(10):1589-1600.

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
Fathi A, Dahlke C, Addo M
HUM VACC IMMUNOTHER . 2019;15(10):2269-2285.

Brain magnetic resonance imaging in imported malaria
Frölich A, Tober-Lau P, Schönfeld M, Brehm T, Kurth F, Vinnemeier C, Addo M, Fiehler J, Rolling T
MALARIA J. 2019;18(1):74.

Rezidivierendes Erbrechen und Kopfschmerzen bei einem 26-jährigen Patienten
Heinemann M, Galaski J, Mager A, Ittrich H, Addo M, Jordan S
INTERNIST. 2019;60(7):756-760.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for primary and secondary prophylaxis of variceal bleeding in hepatic schistosomiasis
Kraef C, Arand J, Galaski J, Jordan S, Kluwe J, Lohse A, Addo M, Ramharter M, Schmiedel S
TRAVEL MED INFECT DI. 2019;30:130-132.

Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
Kraef C, van der Meirschen M, Wichmann D, Kutza M, Restemeyer C, Addo M, Lohse A, Schmiedel S, Kluge S, Schulze Zur Wiesch J

Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Poetsch J, Dahlke C, Zinser M, Kasonta R, Lunemann S, Rechtien A, Ly M, Stubbe H, Krähling V, Biedenkopf N, Eickmann M, Fehling S, Olearo F, Strecker T, Sharma P, Lang K, Lohse A, Schmiedel S, Becker S, Addo M
J INFECT DIS. 2019;219(4):556-561.

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)
Schäfer G, Hoffmann C, Arasteh K, Schürmann D, Stephan C, Jensen B, Stoll M, Bogner J, Faetkenheuer G, Rockstroh J, Klinker H, Härter G, Stöhr A, Degen O, Bibiza-Freiwald E, Hüfner A, Jordan S, Schulze Zur Wiesch J, Addo M, Lohse A, van Lunzen J, Schmiedel S
AIDS RES THER. 2019;16(1):34.

Determinants of post-malarial anemia in African children treated with parenteral artesunate
Scheu K, Adegnika A, Addo M, Ansong D, Cramer J, Fürst S, Kremsner P, Kurth F, Jacobs T, May J, Ramharter M, Sylverken J, Vinnemeier C, Agbenyega T, Rolling T
SCI REP-UK. 2019;9(1):18134.

Author Correction: Differential expression pattern of co-inhibitory molecules on CD4 T cells in uncomplicated versus complicated malaria.
Abel A, Steeg C, Aminkiah F, Addai-Mensah O, Addo M, Gagliani N, Casar C, Yar D, Owusu-Dabo E, Jacobs T, Mackroth M
SCI REP-UK. 2018;8(1):17587.

Differential expression pattern of co-inhibitory molecules on CD4(+) T cells in uncomplicated versus complicated malaria
Abel A, Steeg C, Aminkiah F, Addai-Mensah O, Addo M, Gagliani N, Casar C, Yar D, Owusu-Dabo E, Jacobs T, Mackroth M
SCI REP-UK. 2018;8(1):4789.

Ist die Welt ausreichend gerüstet für das nächste unbekannte Virus?
Addo M
Frankfurter Allgemeine Zeitung. 2018.

Tuberculous Tenosynovitis
Brehm T, Schmiedel S, Addo M
DTSCH ARZTEBL INT. 2018;115(42):714.

Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center.
Brehm T, Schulze zur Wiesch J, Lütgehetmann M, Tappe D, Eisermann P, Lohse A, Addo M, Schmiedel S
INFECTION. 2018;46(6):847-853.

Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV
Fischer T, Spohn M, Olearo F, Zinser M, Kasonta R, Stubbe H, Rechtien A, Ly M, Schmiedel S, Lohse A, Grundhoff A, Addo M, Dahlke C
VACCINE. 2018;36(46):7083-7094.

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
Huttner A, Agnandji S, Combescure C, Fernandes J, Bache E, Kabwende L, Ndungu F, Brosnahan J, Monath T, Lemaître B, Grillet S, Botto M, Engler O, Portmann J, Siegrist D, Bejon P, Silvera P, Kremsner P, Siegrist C
LANCET INFECT DIS. 2018;18(7):738-748.

HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients
Westhölter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, Horvatits T, Gundlach S, Blöcker J, Schulze Zur Wiesch J, Fischer N, Addo M, Peine S, Göke B, Lohse A, Lütgehetmann M, Pischke S
J HEPATOL. 2018;69(1):36-42.

Ebola-Impfstoff-Entwicklung: Im Krisenfall schnell, aber mit hohem Sicherheitsanspruch
Zinser M, Borregaard S, Dahlke C, Addo M
DTSCH ARZTEBL INT. 2018;115(Supplement: Perspektiven der Infektiologie):27-28.

Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 and presence of heme oxygenase-1-specific regulatory T cells
Angin M, Fathi A, King M, Ledoux M, Piechocka-Trocha A, Altfeld M, Addo M
AIDS. 2017;31(5):635-641.

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Dahlke C, Kasonta R, Lunemann S, Krähling V, Zinser M, Biedenkopf N, Fehling S, Ly M, Rechtien A, Stubbe H, Olearo F, Borregaard S, Jambrecina A, Stahl F, Strecker T, Eickmann M, Lütgehetmann M, Spohn M, Schmiedel S, Lohse A, Becker S, Addo M
EBIOMEDICINE. 2017;19:107-118.

Comprehensive characterization of cellular immune responses following Ebola virus infection
Dahlke C, Lunemann S, Kasonta R, Kreuels B, Schmiedel S, Ly M, Fehling S, Strecker T, Becker S, Altfeld M, Sow A, Lohse A, Muñoz-Fontela C, Addo M
J INFECT DIS. 2017;215(2):287-292.

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
Rechtien A, Richert L, Lorenzo H, Martrus G, Hejblum B, Dahlke C, Kasonta R, Zinser M, Stubbe H, Matschl U, Lohse A, Krähling V, Eickmann M, Becker S, Thiébaut R, Altfeld M, Addo M
CELL REP. 2017;20(9):2251-2261.

Pre-travel advice at a crossroad: Medical preparedness of travellers to South and Southeast-Asia - The Hamburg Airport Survey
Rolling T, Mühlenpfordt M, Addo M, Cramer J, Vinnemeier C
TRAVEL MED INFECT DI. 2017;18:41-45.

Helminthic infections in returning travelers and migrants with eosinophilia: Diagnostic value of medical history, eosinophil count and IgE
Salzer H, Rolling T, Vinnemeier C, Tannich E, Schmiedel S, Addo M, Cramer J
TRAVEL MED INFECT DI. 2017;20:49-55.

Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study
Vinnemeier C, Rothe C, Kreuels B, Addo M, Vygen-Bonnet S, Cramer J, Rolling T
MALARIA J. 2017;16(1):44.

Viren überlisten: Globale Virusinfektionen werden beherrschbar - aber neue Gefahren drohen
Addo M, Lohse A
2016. Erkenntnis, Wissenschaft und Gesellschaft. Buchmüller W, Jakobeit C (Hrsg.). 1. Aufl. Springer-Verlag GmbH and Co. KG, 101-118.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Agnandji S, Huttner A, Zinser M, Njuguna P, Dahlke C, Fernandes J, Yerly S, Dayer J, Kraehling V, Kasonta R, Adegnika A, Altfeld M, Auderset F, Bache E, Biedenkopf N, Borregaard S, Brosnahan J, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling S, Finckh A, Goncalves A, Grobusch M, Hooper J, Jambrecina A, Kabwende A, Kaya G, Kimani D, Lell B, Lemaître B, Lohse A, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl F, Staines H, Strecker T, Stubbe H, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny M, Bejon P, Kremsner P, Addo M, Siegrist C
NEW ENGL J MED. 2016;374(17):1647-60.

Molecular Diagnosis of Human Taenia martis Eye Infection
Koch T, Schoen C, Muntau B, Addo M, Ostertag H, Wiechens B, Tappe D
AM J TROP MED HYG. 2016;94(5):1055-7.

Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study
Lehmann M, Brünahl C, Addo M, Becker S, Schmiedel S, Lohse A, Schramm C, Löwe B
J PSYCHOSOM RES. 2016;83:69-74.

Rapid-Antigen Test Negative Malaria in a Traveler Returning From Thailand, Molecularly Diagnosed as Plasmodium knowlesi
Mackroth M, Tappe D, Tannich E, Addo M, Rothe C
Open Forum Infect Dis. 2016;3(1):ofw039.

Sharp increase of imported Plasmodium vivax malaria seen in migrants from Eritrea in Hamburg, Germany
Roggelin L, Tappe D, Noack B, Addo M, Tannich E, Rothe C
MALARIA J. 2016;2016(15):325.

Unique human immune signature of Ebola virus disease in Guinea
Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak D, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore J, Koundouno F, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley L, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue C, Boettcher J, Pallasch E, Sachse A, Bah A, Nitzsche K, Kuisma E, Michel J, Holm T, Zekeng E, García-Dorival I, Wölfel R, Stoecker K, Fleischmann E, Strecker T, Di Caro A, Avšič-Županc T, Kurth A, Meschi S, Mély S, Newman E, Bocquin A, Kis Z, Kelterbaum A, Molkenthin P, Carletti F, Portmann J, Wolff S, Castilletti C, Schudt G, Fizet A, Ottowell L, Herker E, Jacobs T, Kretschmer B, Severi E, Ouedraogo N, Lago M, Negredo A, Franco L, Anda P, Schmiedel S, Kreuels B, Wichmann D, Addo M, Lohse A, De Clerck H, Nanclares C, Jonckheere S, Van Herp M, Sprecher A, Xiaojiang G, Carrington M, Miranda O, Castro C, Gabriel M, Drury P, Formenty P, Diallo B, Koivogui L, Magassouba N, Carroll M, Günther S, Muñoz-Fontela C
NATURE. 2016;533(7601):100-4.

Medizinische Versorgung von Flüchtlingen: Eine Fallserie des Universitätsklinikums Hamburg-Eppendorf
Sothmann P, Schmedt auf der Günne N, Addo M, Lohse A, Schmiedel S
DEUT MED WOCHENSCHR. 2016;141(1):34-37.

Medizinische Versorgung von Flüchtlingen – Eine Fallserie des Universitätsklinikums Hamburg-Eppendorf
Sothmann P, Schmedt auf der Günne N, Roggelin L, Kreuels B, Rothe C, Addo M, Lohse A, Schulze zur Wiesch J, Schmiedel S
FLUGMEDIZIN TROPENME. 2016;23(1):45-49.

Tropheryma whipplei in children with diarrhoea in rural Ghana
Vinnemeier C, Klupp E, Krumkamp R, Rolling T, Fischer N, Owusu-Dabo E, Addo M, Adu-Sarkodie Y, Käsmaier J, Aepfelbacher M, Cramer J, May J, Tannich E
CLIN MICROBIOL INFEC. 2016;22(1):65.e1 - 65.e3.

Geschlechtsunterschiede bei Infektionserkrankungen
Beisel C, Lunzen J, Lohse A, Addo M, Altfeld M
DEUT MED WOCHENSCHR. 2015;140(18):1385-90.

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E
Hartl J, Kreuels B, Polywka S, Addo M, Lütgehetmann M, Dandri-Petersen M, Dammermann W, Sterneck M, Lohse A, Pischke S
Z GASTROENTEROL. 2015;53(7):639-643.

Severe Ebola virus infection complicated by gram-negative septicemia
Kreuels B, Addo M, Schmiedel S
NEW ENGL J MED. 2015;372(14):1377.

Ebola and psychological stress of health care professionals
Lehmann M, Brünahl C, Löwe B, Addo M, Schmiedel S, Lohse A, Schramm C
EMERG INFECT DIS. 2015;21(5):913-914.

Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients
Sada-Ovalle I, Ocaña-Guzman R, Pérez-Patrigeón S, Chávez-Galán L, Sierra-Madero J, Torre-Bouscoulet L, Addo M, Addo M
J INT AIDS SOC. 2015;18(1):20078.

Ex vivo cytosolic delivery of functional macromolecules to immune cells
Sharei A, Trifonova R, Jhunjhunwala S, Hartoularos G, Eyerman A, Lytton-Jean A, Angin M, Sharma S, Poceviciute R, Mao S, Heimann M, Liu S, Talkar T, Khan O, Addo M, von Andrian U, Anderson D, Langer R, Lieberman J, Jensen K
PLOS ONE. 2015;10(4):e0118803.

Sex-based differences in HIV type 1 pathogenesis
Addo M, Altfeld M
J INFECT DIS. 2014;209 Suppl 3(Suppl 3):S86-92.

Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity
Angin M, Klarenbeek P, King M, Sharma S, Moodley E, Rezai A, Piechocka-Trocha A, Toth I, Chan A, Goulder P, Ndung'u T, Kwon D, Addo M
PLOS ONE. 2014;9(2):e86920.

HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis
Angin M, Sharma S, King M, Murooka T, Ghebremichael M, Mempel T, Walker B, Bhasin M, Addo M
J INFECT DIS. 2014;210(6):899-903.

A dead-end host: is there a way out? A position piece on the ebola virus outbreak by the international union of immunology societies
Gray C, Addo M, Schmidt R
FRONT IMMUNOL. 2014;5:562.

A case of severe Ebola virus infection complicated by gram-negative septicemia
Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, Heer G, Kluge S, Sow A, Renné T, Günther S, Lohse A, Addo M, Schmiedel S
NEW ENGL J MED. 2014;371(25):2394-401.

New tools to expand regulatory T cells from HIV-1-infected individuals
Angin M, King M, Addo M
JOVE-J VIS EXP. 2013;(75):e50244.

Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
Jost S, Moreno-Nieves U, Garcia-Beltran W, Rands K, Reardon J, Toth I, Piechocka-Trocha A, Altfeld M, Addo M
RETROVIROLOGY. 2013;10:74.

Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection
Vaidya S, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon D, Addo M, Rychert J, Routy J, Jessen H, Kelleher A, Hecht F, Sekaly R, Carrington M, Walker B, Allen T, Rosenberg E, Altfeld M
RETROVIROLOGY. 2013;10:139.

Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers.
Angin M, King M, Altfeld M, Walker B, Wucherpfennig K, Addo M
AIDS. 2012;26(16):2112-2115.

Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue.
Angin M, Kwon D, Streeck H, Wen F, King M, Rezai A, Law K, Hongo T, Pyo A, Piechocka-Trocha A, Toth I, Pereyra F, Ghebremichael M, Rodig S, Milner D, Richter J, Altfeld M, Kaufmann D, Walker B, Addo M
J INFECT DIS. 2012;205(10):1495-1500.

Regulatory T cell frequencies do not correlate with breadth or magnitude of HIV-1-specific T cell responses.
Angin M, Streeck H, Wen F, King M, Pereyra F, Altfeld M, Walker B, Addo M
AIDS RES HUM RETROV. 2012;28(8):749-751.

Primary HIV-1 infection is associated with increased plasma levels of heme-oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells.
Fathi A, Angin M, King M, Piechocka-Trocha A, Altfeld M, Walker B, Addo M
2012. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA. .

CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.
Kwon D, Angin M, Hongo T, Law K, Johnson J, Porichis F, Hart M, Pavlik D, Tighe D, Kavanagh D, Streeck H, Addo M, Kaufmann D
J VIROL. 2012;86(12):6586-6594.

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.
Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A, Angin M, Wakeham A, Greenfield E, Sobel R, Okada H, McKinnon P, Mak T, Addo M, Anderson A, Kuchroo V
NAT MED. 2012;18(9):1394-1400.

Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals.
Addo M, Altfeld M, Brainard D, Rathod A, Piechocka-Trocha A, Fideli U, Mulenga J, Shutes E, Alvino D, Hunter E, Allen S, Walker B
J INFECT DIS. 2011;203(2):258-262.

Increased plasma levels of hemoxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells in acute HIV-1 infection
Angin M, Fathi A, King M, Addo M
2011. AIDS Vaccine Conference 2011, Bangkok, Thailand. .

Impact of heme oxygenase-1 specific CD8+ regulatory T cells on HIV-1 immunity
Fathi A, Angin M, King M, Addo M
2011. Scientific Advisory Committee 2011 Poster Session, Massachusetts General Hospital, Boston, MA, USA. .

Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
Julg B, Pereyra F, Buzón M, Piechocka-Trocha A, Clark M, Baker B, Lian J, Miura T, Martinez-Picado J, Addo M, Walker B
CLIN INFECT DIS. 2010;51(2):233-238.

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Study I, Pereyra F, Jia X, McLaren P, Telenti A, Bakker d, Paul I, Walker B, Ripke S, Brumme C, Pulit S, Carrington M, Kadie C, Carlson J, Heckerman D, Graham R, Plenge R, Deeks S, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore J, Beattie N, Gupta S, Crenshaw A, Burtt N, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss K, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino D, Addo M, Addo M, Allen T, Altfeld M, Henn M, Sylvie L, Streeck H, Haas D, Kuritzkes D, Robbins G, Shafer R, Gulick R, Shikuma C, Haubrich R, Riddler S, Sax P, Daar E, Ribaudo H, Agan B, Agarwal S, Ahern R, Allen B, Altidor S, Altschuler E, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos N, Benson A, Berger J, Bernard N, Bernard A, Birch C, Bodner S, Bolan R, Boudreaux E, Bradley M, Braun J, Brndjar J, Brown S, Brown K, Brown S, Burack J, Bush L, Cafaro V, Campbell O, Campbell J, Carlson R, Carmichael J, Casey K, Cavacuiti C, Celestin G, Chambers S, Chez N, Chirch L, Cimoch P, Cohen D, Cohn L, Conway B, Cooper D, Cornelson B, Cox D, Cristofano M, Cuchural G, Czartoski J, Dahman J, Daly J, Davis B, Davis K, Davod S, DeJesus E, Dietz C, Dunham E, Dunn M, Ellerin T, Eron J, Fangman J, Farel C, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg K, French N, Fuchs J, Fuller J, Gaberman J, Gallant J, Gandhi R, Garcia E, Garmon D, Gathe J, Gaultier C, Gebre W, Gilman F, Gilson I, Goepfert P, Gottlieb M, Goulston C, Groger R, Gurley T, Haber S, Hardwicke R, Hardy W, Harrigan P, Hawkins T, Heath S, Hecht F, Henry W, Hladek M, Hoffman R, Horton J, Hsu R, Huhn G, Hunt P, Hupert M, Illeman M, Jaeger H, Jellinger R, John M, Johnson J, Johnson K, Johnson H, Johnson K, Joly J, Jordan W, Kauffman C, Khanlou H, Killian R, Kim A, Kim D, Kinder C, Kirchner J, Kogelman L, Kojic E, Korthuis P, Kurisu W, Kwon D, LaMar M, Lampiris H, Lanzafame M, Lederman M, Lee D, Lee J, Lee M, Lee E, Lemoine J, Levy J, Llibre J, Liguori M, Little S, Liu A, Lopez A, Loutfy M, Loy D, Mohammed D, Man A, Mansour M, Marconi V, Markowitz M, Marques R, Martin J, Martin H, Mayer K, McElrath M, McGhee T, McGovern B, McGowan K, McIntyre D, Mcleod G, Menezes P, Mesa G, Metroka C, Meyer-Olson D, Miller A, Montgomery K, Mounzer K, Nagami E, Nagin I, Nahass R, Nelson M, Nielsen C, Norene D, O'Connor D, Ojikutu B, Okulicz J, Oladehin O, Oldfield E, Olender S, Ostrowski M, Owen W, Pae E, Parsonnet J, Pavlatos A, Perlmutter A, Pierce M, Pincus J, Pisani L, Price L, Proia L, Prokesch [
SCIENCE. 2010;330(6010):1551-1557.

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1
Kim A, Lauer G, Ouchi K, Addo M, Lucas M, Schulze Zur Wiesch J, Timm J, Boczanowski M, Duncan J, Wurcel A, Casson D, Chung R, Draenert R, Klenerman P, Walker B
BLOOD. 2005;105(3):1170-8.

Vpr is preferentially targeted by CTL during HIV-1 infection

J IMMUNOL. 2001;167(5):2743-52.

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
Addo M, Altfeld M, Rosenberg E, Eldridge R, Philips M, Habeeb K, Khatri A, Brander C, Robbins G, Mazzara G, Goulder P, Walker B
P NATL ACAD SCI USA. 2001;98(4):1781-6.

Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
Altfeld M, Livingston B, Reshamwala N, Nguyen P, Addo M, Shea A, Newman M, Fikes J, Sidney J, Wentworth P, Chesnut R, Eldridge R, Rosenberg E, Robbins G, Brander C, Sax P, Boswell S, Flynn T, Buchbinder S, Goulder P, Walker B, Sette A, Kalams S
J VIROL. 2001;75(3):1301-11.

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
Altfeld M, Rosenberg E, Shankarappa R, Mukherjee J, Hecht F, Eldridge R, Addo M, Poon S, Phillips M, Robbins G, Sax P, Boswell S, Kahn J, Brander C, Goulder P, Levy J, Mullins J, Walker B
J EXP MED. 2001;193(2):169-80.

Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays
Goulder P, Addo M, Altfeld M, Rosenberg E, Tang Y, Govender U, Mngqundaniso N, Annamalai K, Vogel T, Hammond M, Bunce M, Coovadia H, Walker B
J VIROL. 2001;75(3):1339-47.

Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection
Goulder P, Altfeld M, Rosenberg E, Nguyen T, Tang Y, Eldridge R, Addo M, He S, Mukherjee J, Phillips M, Bunce M, Kalams S, Sekaly R, Walker B, Brander C
J EXP MED. 2001;193(2):181-94.

Evolution and transmission of stable CTL escape mutations in HIV infection
Goulder P, Brander C, Tang Y, Tremblay C, Colbert R, Addo M, Rosenberg E, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton S, Burchett S, McIntosh K, Korber B, Walker B
NATURE. 2001;412(6844):334-8.

T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions
Altfeld M, Addo M, Kreuzer K, Rockstroh J, Dumoulin F, Schliefer K, Leifeld L, Sauerbruch T, Spengler U
JAIDS-J ACQ IMM DEF. 2000;23(4):287-94.

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay
Altfeld M, Trocha A, Eldridge R, Rosenberg E, Phillips M, Addo M, Sekaly R, Kalams S, Burchett S, McIntosh K, Walker B, Goulder P
J VIROL. 2000;74(18):8541-9.

Influence of protease inhibitor therapy on lipoprotein metabolism
Berthold H, Parhofer K, Ritter M, Addo M, Wasmuth J, Schliefer K, Spengler U, Rockstroh J
J INTERN MED. 1999;246(6):567-75.

Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal
Altfeld M, Rockstroh J, Addo M, Kupfer B, Pult I, Will H, Spengler U
J HEPATOL. 1998;29(2):306-9.

Transmission of oral Candida albicans strains between HIV-positive patients
Boerlin P, Addo M, Boerlin-Petzold F, Durussel C, Pagani J, Chave J, Bille J
LANCET. 1995;345(8956):1052-3.

Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users
Boerlin P, Boerlin-Petzold F, Durussel C, Addo M, Pagani J, Chave J, Bille J
J CLIN MICROBIOL. 1995;33(5):1129-35.

Letzte Aktualisierung aus dem FIS: 06.12.2021 - 00:35 Uhr

Zertifikat - Assoziierte Klinik der Deutschen Leberstiftung 2021
European Reference Network for rare or low prevalence complex diseases //Network, Hepatological Diseases (ERN RARE-LIVER)
Logo SFB841 - Projekt: Leberentzündung: Infektion, Immunregulation und Konsequenzen
Logo KFO306 - Projekt: Primär Sklerosierende Cholangitis
Logo ENETS - European Neuroendocrine Tumor Society
Signet - Deutsche Gesellschaft für Infektiologie e.V.
Signet - Deutsches Zentrum für Infektionsforschung